期刊文献+

氟康唑在门诊的合理应用及处方分析 被引量:2

The Reasonable Use and Prescription Analysis of Fluconazole in Outpatient Service
下载PDF
导出
摘要 目的:考查氟康唑在我院门诊应用的合理性和治疗效果及取药情况,为临床合理应用提供指导。方法:从门诊各科了解诊疗用药后的治愈情况,对我院2006年9月~2007年9月所有氟康唑处方作分析。结果:处方合理用药率达到96.4%,外流处方71.9%,治疗效果61.8%。结论:氟康唑在我院门诊从处方上反映大多应用合理,处方大量外流,不合理用药表现在联合应用和用法不当,部分治疗失败。 OBJECTIVE: to check the reasonable, the treating effect and medicine - getting situations of Fluconazole that was used in the outpatient service in our hospital, providing instructions for using it reasonably. METHODS: From all the departments of the outpatient service to know about the curing after being treated with Fluconazole; To analyze all the Fluconazole prescriptions from September, 2006 to September, 2007. RESULTS: The reasonable medicine- using rate amounted to 96.4%. out of lowing prescriptions reached 71.9% and the treating effect was 61.8%. CONCLUSION: Fluconazole in the outpatient service of our hospital reflected most of the reasonable use. A lot of prescriptions outflew, the unreasonable medicine use was the joint use and misusing, so part of the treatments failed.
作者 何宣蓉
出处 《中国医院用药评价与分析》 2008年第1期25-27,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 氟康唑 抗真菌治疗 真菌感染 Fluconazole Anti - fungus treatment Fungus infection
  • 相关文献

参考文献4

二级参考文献21

  • 1农生洲,王勇,唐萍,覃桂芳,陈松锋.临床分离致病性真菌的菌种类型调查及其耐药谱分析[J].中国基层医药,2004,11(10):1209-1210. 被引量:4
  • 2张石革,王爱霞.抗感染合理用药专家圆桌会纪要[J].中国医院用药评价与分析,2005,5(5):259-263. 被引量:22
  • 3Loeffler J.Stevens DA.Antifungal drug resisitance[J].Clin Int Dis,2003,36(1):31-41.
  • 4Garbino J,Lew D,Hirschel B,et al.Caspofungin in the treatment of oropharyngeal candidiasis[J].Int J Clin Pract,2003,57(2):143-144.
  • 5Li RK,Rinaldi MG.In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole[J].Antimicrob Agents Chemother,1999,43(6):1401-1405.
  • 6Plaller MA,Diekema DJ,Messer SA.In vitro activities of voriconazole,posaconazole and four licensed systemic antifungal agents against Canadida species infrequently isolatied from bllod [J].J Clin Microbiol,2003,41(1):78-83.
  • 7Hoban DJ,Zhanel GG,Karlowsky JK.In vitro susceptibities of candida and cryptococcus neoformans isolates from blood cultures of neutropenic patients[J].Antimicrob Agents Chemother,1999,43(6):1463-1464.
  • 8Abraham OC, Manavathu EK,Cutright JL,et al.In vitro susceptibities of aspergillus species to voriconazole,itraconazole and amphotericin B [J].Microbiol Infect Dis,1999,33(1):7-11.
  • 9Fukuoka T,Johnston DA,Winslow CA,et al.Genitic basis for differential activities of fluconazole and voriconazole against candida krusel[J].Antimicrob Agents Chemother,2003,47(4):1213-1219.
  • 10Chandrasekar PH,Manavathu E.Voriconazole:A second-generation triazole[J].Drugs Today,2001,37(2):135-148.

共引文献13

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部